Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Combining vasculature disrupting agent and Toll-like receptor 7/8 agonist for cancer therapy.

PropertyValue
has major subject area list Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Imidazoles; Melanoma, Experimental; Toll-Like Receptor 7; Toll-Like Receptor 8; Xanthones
information resource reference Seth A, Lee H, Cho MY, Park C, Korm S, Lee JY, Choi I, Lim YT, Hong KS. Combining vasculature disrupting agent and Toll-like receptor 7/8 agonist for cancer therapy. Oncotarget. 2017 Jan 17; 8(3):5371-5381. PMID: 28036266.
label Combining vasculature disrupting agent and Toll-like receptor 7/8 agonist for cancer therapy.

Highlights
Search Criteria
  • Toll like receptors